Blog

March is National Multiple Sclerosis Awareness month. When the COVID-19 pandemic first emerged, there were many questions about how persons with Multiple Sclerosis (MS) would be affected.  Now a year later, we have answers to some of those questions, and other issues that have yet...

The Visual Healing® study at PNI tests a nature-themed immersive video experience in psilocybin-assisted therapy for patients with alcohol use disorder.

Cancer takes a toll on the mind, too, no matter what organ system it affects. Dr. Shanthi Gowrinathan has seen all of these things. She’s the Director of Psycho-Oncology at PNI, and she specializes in the mental health of cancer patients.

A South Bay man survives a life-threatening brain aneurysm thanks to a rapid medical response at Providence Little Company Medical Center in Torrance, California. Charles Demachy, a local SoCal plant nursery owner, remembers the headache most of all. It was crushing and “weird,” he says....

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...